Neurology

A systematic review of 20 studies has found that deep brain stimulation of the subthalamic nucleus (STN-DBS), a widely used treatment for Parkinson’s disease (PD), may lead to unexpected gait and balance worsening in some patients.

Cognitive decline in relapsing-remitting multiple sclerosis (RRMS) can progress independently of both relapses and MRI-detected disease activity, challenging traditional methods of monitoring MS progression, according to the results of a new study.

A machine-learning classifier designed to assist healthcare professionals in accurately diagnosing the causes of transient loss of consciousness (TLOC) has been introduced in a new study.

Financial challenges faced by family surrogate decision-makers of stroke patients were highlighted in a new study that revealed that nearly half experience moderate to severe concerns about affording stroke-related medical expenses.

A significant association between smoking and the occurrence of cryptogenic ischemic strokes (CIS) in young adults has been published in a new study.

New findings presented at the ACTRIMS Forum 2025 highlight how the latest revisions to the McDonald Criteria could reshape the diagnosis of multiple sclerosis (MS), allowing for earlier identification in patients with radiologically isolated syndrome (RIS) and atypical clinical presentations.

At the ACTRIMS Forum 2025 in West Palm Beach, Florida, researchers unveiled compelling findings on the effects of a 6-month modified Atkins diet (MAD), a less restrictive form of the ketogenic diet, on patients with relapsing multiple sclerosis (MS).

A new analysis of Phase III clinical trial data presented at the ACTRIMS Forum 2025 in West Palm Beach, Florida, suggests that tolebrutinib, a Bruton’s tyrosine kinase inhibitor (BTKi), may be effective in multiple sclerosis (MS) with chronic active lesions.